193 related articles for article (PubMed ID: 26973396)
41. Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study.
Benson AB; Geschwind JF; Mulcahy MF; Rilling W; Siskin G; Wiseman G; Cunningham J; Houghton B; Ross M; Memon K; Andrews J; Fleming CJ; Herman J; Nimeiri H; Lewandowski RJ; Salem R
Eur J Cancer; 2013 Oct; 49(15):3122-30. PubMed ID: 23777743
[TBL] [Abstract][Full Text] [Related]
42. Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization.
Abdelmaksoud MH; Louie JD; Kothary N; Hwang GL; Kuo WT; Hofmann LV; Hovsepian DM; Sze DY
J Vasc Interv Radiol; 2011 Oct; 22(10):1364-1371.e1. PubMed ID: 21961981
[TBL] [Abstract][Full Text] [Related]
43. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
Dawson LA
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
[No Abstract] [Full Text] [Related]
44. A first report of radioembolization for hepatic metastases from ocular melanoma.
Kennedy AS; Nutting C; Jakobs T; Cianni R; Notarianni E; Ofer A; Beny A; Dezarn WA
Cancer Invest; 2009 Jul; 27(6):682-90. PubMed ID: 19219675
[TBL] [Abstract][Full Text] [Related]
45. Splenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization.
Lam MG; Banerjee A; Louie JD; Sze DY
Cardiovasc Intervent Radiol; 2014 Aug; 37(4):1009-17. PubMed ID: 24091754
[TBL] [Abstract][Full Text] [Related]
46. Safety of Radioembolization with (90)Yttrium Resin Microspheres Depending on Coiling or No-Coiling of Aberrant/High-Risk Vessels.
Paprottka PM; Paprottka KJ; Walter A; Haug AR; Trumm CG; Lehner S; Fendler WP; Jakobs TF; Reiser MF; Zech CJ
Cardiovasc Intervent Radiol; 2015 Aug; 38(4):946-56. PubMed ID: 25986465
[TBL] [Abstract][Full Text] [Related]
47. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
[TBL] [Abstract][Full Text] [Related]
48. Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
Kokabi N; Camacho JC; Xing M; El-Rayes BF; Spivey JR; Knechtle SJ; Kim HS
Cancer; 2015 Jul; 121(13):2164-74. PubMed ID: 25847227
[TBL] [Abstract][Full Text] [Related]
49. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.
Murthy R; Brown DB; Salem R; Meranze SG; Coldwell DM; Krishnan S; Nunez R; Habbu A; Liu D; Ross W; Cohen AM; Censullo M
J Vasc Interv Radiol; 2007 Apr; 18(4):553-61; quiz 562. PubMed ID: 17446547
[TBL] [Abstract][Full Text] [Related]
50. The Utility of Unilobar Technetium-99m Macroaggregated Albumin to Predict Pulmonary Toxicity In Bilobar Hepatocellular Carcinoma prior to Yttrium-90 Radioembolization.
Kallini JR; Gabr A; Kulik L; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1453-1456. PubMed ID: 27566430
[No Abstract] [Full Text] [Related]
51. Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: efficacy, safety and prognostic factors.
Michl M; Haug AR; Jakobs TF; Paprottka P; Hoffmann RT; Bartenstein P; Boeck S; Haas M; Laubender RP; Heinemann V
Oncology; 2014; 86(1):24-32. PubMed ID: 24401529
[TBL] [Abstract][Full Text] [Related]
52. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
Allison C
Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
[TBL] [Abstract][Full Text] [Related]
53. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L
Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
[TBL] [Abstract][Full Text] [Related]
54. Radioembolisation with Yttrium-90 microspheres: an effective treatment modality for unresectable liver metastases.
Bester L; Meteling B; Pocock N; Saxena A; Chua TC; Morris DL
J Med Imaging Radiat Oncol; 2013 Feb; 57(1):72-80. PubMed ID: 23374558
[TBL] [Abstract][Full Text] [Related]
55. Liver radioembolization using 90Y resin microspheres in elderly patients: tolerance and outcome.
Iñarrairaegui M; Bilbao JI; RodrÃguez M; Benito A; Sangro B
Hosp Pract (1995); 2010; 38(3):103-9. PubMed ID: 20890058
[TBL] [Abstract][Full Text] [Related]
56. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization.
Murthy R; Kamat P; Nunez R; Madoff DC; Gupta S; Salem R; Yao JC
J Vasc Interv Radiol; 2008 Jan; 19(1):145-51. PubMed ID: 18192482
[TBL] [Abstract][Full Text] [Related]
57. Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization.
Abdelmaksoud MH; Louie JD; Kothary N; Hwang GL; Kuo WT; Hofmann LV; Hovsepian DM; Sze DY
J Vasc Interv Radiol; 2011 Oct; 22(10):1355-62. PubMed ID: 21961979
[TBL] [Abstract][Full Text] [Related]
58. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
Welsh JS; Kennedy AS; Thomadsen B
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
[TBL] [Abstract][Full Text] [Related]
59. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
[TBL] [Abstract][Full Text] [Related]
60. Biliary sequelae following radioembolization with Yttrium-90 microspheres.
Atassi B; Bangash AK; Lewandowski RJ; Ibrahim S; Kulik L; Mulcahy MF; Murthy R; Ryu RK; Sato KT; Miller FH; Omary RA; Salem R
J Vasc Interv Radiol; 2008 May; 19(5):691-7. PubMed ID: 18440457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
